Key facts
- It has raised $31.5M across 3 recorded rounds; the latest was Early Stage VC ($26.0M) in Aug 2025.
- Notable investors include Maverick Ventures, Blue Venture Fund, Healthier Capital, Oncology Ventures, Yosemite.
- Daymark Health has filed 3 Form Ds with the SEC since 2024, most recently Sep 2025 ($26.0M sold to 7 investors).
- Status: Privately Held (backing).
Leadership
- Brian LovettFounder
- Paul DufaultChief Operating Officer
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Daymark Health
Funding rounds
3 roundsAbout Daymark Health
Operator of a supportive care services company intended for cancer patients. The company's platform connects primary care physicians, oncologists, and care teams to offer virtual and home-based care, symptom management, care navigation, social support, and mental health services delivered by nurse practitioners, social workers, and health partners, enabling cancer patients to receive comprehensive, personalized care that addresses both medical and non-medical needs throughout their treatment journey.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2022
- Website
- daymarkhealth.com/
- Ownership
- Privately Held (backing)
Daymark Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Daymark Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Daymark Health in its N-PORT filings yet. We sweep new filings monthly.